Resultados de la búsqueda 321-330 of 10349 for hla genotype

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patient-derived xenograft (PDX) models are considerate the most representative pre-clinical model of human cancer, recapitulating the key characteristics of the ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to critically test the hypothesis that senescent-cell derived factors (cell aging), in particular IGFBP3, suppress the innate ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn., Jacksonville, Fla. To collect post-approval data comparing the safety and effectiveness of CraniSeal Dural Sealant to DuraSeal Dural Sealant.

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of this proposal is to develop a Thoracic Specimen Registry at Mayo Clinic. The purpose of the registry will be to support ongoing ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and docetaxel ...

  9. Salud del adulto - Mayo Clinic

    News · enero 2026 · noviembre 2025 · octubre 2025 · septiembre 2025 · agosto 2025 · julio 2025 · mayo 2025 · abril 2025.

  10. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in patients ...